顯示所有 14 筆結果
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-26.0-BT)
-
Anti-CD20 [10F381 (rituximab)] (Ab00126-26.0)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-26.0-BT)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-26.0)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-37.0-BT)
-
Anti-CD22 [hL22 (Epratuzumab)] (Ab00728-37.0)
-
Anti-CD52 [Campath-1H] (Ab00124-26.0-BT)
-
Anti-CD52 [Campath-1H] (Ab00124-26.0)
-
Anti-Glycoprotein Complex [37.7H] (Ab01102-35.0-BT)
-
Anti-Glycoprotein Complex [37.7H] (Ab01102-35.0)
-
Anti-IL-2R [Daclizumab] (Ab00187-26.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-26.0)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-26.0-BT)
-
Anti-IL-2R alpha (CD25) [Basiliximab] (Ab00188-26.0)
